Effect of long-term maternal smoking on the offspring’s lung health

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 313, Issue 2, 2017, Pages L416-L423

  Sukjamnong, Surpon ^a,d   Chan, Yik Lung ^a,b   Zakarya, Razia ^a,b   Saad, Sonia ^a,c   Sharma, Pawan ^a,b   Santiyanont, Rachana ^d   Chen, Hui ^a   Oliver, Brian G ^a,b  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

^d CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Receptors for advanced glycation end products

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTIOXIDANT; CIGARETTE SMOKE; COLLAGEN TYPE 1; COLLAGEN TYPE 1A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOQUINONE MESYLATE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; SMOKE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRTH WEIGHT; BODY WEIGHT; CONTROLLED STUDY; FEMALE; LACTATION; LONG TERM EXPOSURE; LUNG FIBROSIS; MALE; MATERNAL EXPOSURE; MATERNAL SMOKING; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ADVERSE EFFECTS; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; INFLAMMATION; LUNG; METABOLISM; PATHOLOGY; PREGNANCY; PRENATAL EXPOSURE; SIGNAL TRANSDUCTION; SMOKE; SMOKING; TOBACCO;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; FEMALE; INFLAMMATION; LUNG; MALE; MATERNAL EXPOSURE; MICE; MICE, INBRED BALB C; MITOCHONDRIA; OXIDATIVE STRESS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SIGNAL TRANSDUCTION; SMOKE; SMOKING; TOBACCO;

EID: 85026778125     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00134.2017     Document Type: Article

References (66)

1. Al-Bazi MM, Elshal MF, Khoja SM. Reduced coenzyme Q(10) in female smokers and its association with lipid profile in a young healthy adult population. Arch Med Sci 7: 948–954, 2011. doi:10.5114/aoms. 2011.26605.
2. Al-Odat I, Chen H, Chan YL, Amgad S, Wong MG, Gill A, Pollock C, Saad S. The impact of maternal cigarette smoke exposure in a rodent model on renal development in the offspring. PLoS One 9: e103443, 2014. doi:10.1371/journal.pone.0103443.
3. Antonicelli F, Parmentier M, Drost EM, Hirani N, Rahman I, Donaldson K, MacNee W. Nacystelyn inhibits oxidant-mediated interleu-kin-8 expression and NF-kappaB nuclear binding in alveolar epithelial cells. Free Radic Biol Med 32: 492–502, 2002. doi:10.1016/S0891-5849(01)00820-6.
4. Basyigit I, Tugay M, Dilioglugil MO, Yildiz F, Maral H, Sozubir S. Protective effects of N-acetylcysteine on peroxidative changes of the fetal rat lungs whose mothers were exposed to cigarette smoke. Hum Exp Toxicol 26: 99–103, 2007. doi:10.1177/0960327107071917.
5. Bernardo I, Bozinovski S, Vlahos R. Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities. Pharmacol Ther 155: 60–79, 2015. doi:10.1016/j.pharmthera.2015.08.005.
6. Candas D, Li JJ. MnSOD in oxidative stress response-potential regulation via mitochondrial protein influx. Antioxid Redox Signal 20: 1599– 1617, 2014. doi:10.1089/ars.2013.5305.
7. Carroll KN, Gebretsadik T, Griffin MR, Dupont WD, Mitchel EF, Wu P, Enriquez R, Hartert TV. Maternal asthma and maternal smoking are associated with increased risk of bronchiolitis during infancy. Pediatrics 119: 1104–1112, 2007. doi:10.1542/peds.2006-2837.
8. Cerami C, Founds H, Nicholl I, Mitsuhashi T, Giordano D, Vanpatten S, Lee A, Al-Abed Y, Vlassara H, Bucala R, Cerami A. Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci USA 94: 13915–13920, 1997. doi:10.1073/pnas.94.25.13915.
9. -(AkitaJ) mice by the mitochondria-targeted therapy MitoQ. Biochem J 432: 9–19, 2010. doi: 10.1042/BJ20100308.
10. Chan YL, Saad S, Pollock C, Oliver B, Al-Odat I, Zaky AA, Jones N, Chen H. Impact of maternal cigarette smoke exposure on brain inflammation and oxidative stress in male mice offspring. Sci Rep 6: 25881, 2016. doi:10.1038/srep25881.
11. Chan YL, Saad S, Pollock C, Oliver B, Al-Odat I, Zaky AA, Jones N, Chen H. Impact of maternal cigarette smoke exposure on brain inflammation and oxidative stress in male mice offspring. Sci Rep 6: 25881, 2016. doi:10.1038/srep25881.
12. Chelchowska M, Ambroszkiewicz J, Gajewska J, Laskowska-Klita T, Leibschang J. The effect of tobacco smoking during pregnancy on plasma oxidant and antioxidant status in mother and newborn. Eur J Obstet Gynecol Reprod Biol 155: 132–136, 2011. doi:10.1016/j.ejogrb.2010.12.006.
13. Chen L, Wang T, Guo L, Shen Y, Yang T, Wan C, Liao Z, Xu D, Wen F. Overexpression of RAGE contributes to cigarette smoke-induced nitric oxide generation in COPD. Lung 192: 267–275, 2014. doi:10.1007/s00408-014-9561-1.
14. Collins MH, Moessinger AC, Kleinerman J, Bassi J, Rosso P, Collins AM, James LS, Blanc WA. Fetal lung hypoplasia associated with maternal smoking: a morphometric analysis. Pediatr Res 19: 408–412, 1985. doi:10.1203/00006450-198519040-00018.
15. Daffu G, del Pozo CH, O’Shea KM, Ananthakrishnan R, Ramasamy R, Schmidt AM. Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond. Int J Mol Sci 14: 19891– 19910, 2013. doi:10.3390/ijms141019891.
16. Demling N, Ehrhardt C, Kasper M, Laue M, Knels L, Rieber EP. Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells. Cell Tissue Res 323: 475–488, 2006. doi:10.1007/s00441-005-0069-0.
17. Elliot J, Carroll N, Bosco M, McCrohan M, Robinson P. Increased airway responsiveness and decreased alveolar attachment points following in utero smoke exposure in the guinea pig. Am J Respir Crit Care Med 163: 140–144, 2001. doi:10.1164/ajrccm.163.1.9805099.
18. Ermis B, Ors R, Yildirim A, Tastekin A, Kardas F, Akcay F. Influence of smoking on maternal and neonatal serum malondialdehyde, superoxide dismutase, and glutathione peroxidase levels. Ann Clin Lab Sci 34: 405–409, 2004.
19. Garbin U, Fratta Pasini A, Stranieri C, Cominacini M, Pasini A, Manfro S, Lugoboni F, Mozzini C, Guidi G, Faccini G, Cominacini L. Cigarette smoking blocks the protective expression of Nrf2/ARE pathway in peripheral mononuclear cells of young heavy smokers favouring inflammation. PLoS One 4: e8225, 2009. doi:10.1371/journal.pone.0008225.
20. Gassman JR, Lewis JB, Milner DC, Lewis AL, Bodine JS, Dunaway TM, Monson TD, Broberg DS, Arroyo JA, Reynolds PR. Spatial expression of receptor for advanced glycation end-products (RAGE) in diverse tissue and organ systems differs following exposure to secondhand cigarette smoke. FASEB J 30: lb741, 2016.
21. Gilliland FD, Li YF, Peters JM. Effects of maternal smoking during pregnancy and environmental tobacco smoke on asthma and wheezing in children. Am J Respir Crit Care Med 163: 429–436, 2001. doi:10.1164/ajrccm.163.2.2006009.
22. Guo C, Sun L, Chen X, Zhang D. Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res 8: 2003–2014, 2013. doi:10.3969/j.issn.1673-5374.2013.21.009.
23. Hernandez A, Omini C, Daffonchio L. Interleukin-1 beta: a possible mediator of lung inflammation and airway hyperreactivity. Pharmacol Res 24: 385–393, 1991. doi:10.1016/1043-6618(91)90043-W.
24. Hsu WH, Lee BH, Pan TM. Monascin attenuates oxidative stress-mediated lung inflammation via peroxisome proliferator-activated recep-tor-gamma (PPAR-κ) and nuclear factor-erythroid 2 related factor 2 (Nrf-2) modulation. J Agric Food Chem 62: 5337–5344, 2014. doi:10.1021/jf501373a.
25. John G, Kohse K, Orasche J, Reda A, Schnelle-Kreis J, Zimmer-mann R, Schmid O, Eickelberg O, Yildirim AO. The composition of cigarette smoke determines inflammatory cell recruitment to the lung in COPD mouse models. Clin Sci Lond 126: 207–221, 2014. doi:10.1042/CS20130117.
26. Kelso GF, Porteous CM, Coulter CV, Hughes G, Porteous WK, Ledgerwood EC, Smith RA, Murphy MP. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem 276: 4588–4596, 2001. doi:10.1074/jbc.M009093200.
27. Kim SR, Lee KS, Park SJ, Min KH, Lee KY, Choe YH, Hong SH, Koh GY, Lee YC. Angiopoietin-1 variant, COMP-Ang1 attenuates hydrogen peroxide-induced acute lung injury. Exp Mol Med 40: 320–331, 2008. doi:10.3858/emm.2008.40.3.320.
28. Kuschner WG, D’Alessandro A, Wong H, Blanc PD. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 9: 1989–1994, 1996. doi:10.1183/09031936.96.09101989.
29. Kyrklund-Blomberg NB, Granath F, Cnattingius S. Maternal smoking and causes of very preterm birth. Acta Obstet Gynecol Scand 84: 572–577, 2005. doi:10.1111/j.0001-6349.2005.00848.x.
30. Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt AM. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272: 17810–17814, 1997. doi:10.1074/jbc.272.28.17810.
31. Lappalainen U, Whitsett JA, Wert SE, Tichelaar JW, Bry K. Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol 32: 311–318, 2005. doi:10.1165/rcmb.2004-0309OC.
32. Lin L, Park S, Lakatta EG. RAGE signaling in inflammation and arterial aging. Front Biosci (Landmark Ed) 14: 1403–1413, 2009. doi:10.2741/3315.
33. Lowes DA, Thottakam BM, Webster NR, Murphy MP, Galley HF. The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis. Free Radic Biol Med 45: 1559–1565, 2008. doi:10.1016/j.freeradbiomed.2008.09.003.
34. Manczak M, Mao P, Calkins MJ, Cornea A, Reddy AP, Murphy MP, Szeto HH, Park B, Reddy PH. Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer’s disease neurons. J Alzheimers Dis 20, Suppl 2: S609–S631, 2010. doi:10.3233/JAD-2010-100564.
35. McKay S, Sharma HS. Autocrine regulation of asthmatic airway inflammation: role of airway smooth muscle. Respir Res 3: 11, 2002. doi:10.1186/rr160.
36. Mercer JR, Yu E, Figg N, Cheng KK, Prime TA, Griffin JL, Masoodi M, Vidal-Puig A, Murphy MP, Bennett MR. The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/
37. Milner AD, Rao H, Greenough A. The effects of antenatal smoking on lung function and respiratory symptoms in infants and children. Early Hum Dev 83: 707–711, 2007. doi:10.1016/j.earlhumdev.2007.07.014.
38. Mukhopadhyay P, Horváth B, Zsengellér Z, Zielonka J, Tanchian G, Holovac E, Kechrid M, Patel V, Stillman IE, Parikh SM, Joseph J, Kalyanaraman B, Pacher P. Mitochondrial-targeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathy. Free Radic Biol Med 52: 497–506, 2012. doi:10.1016/j.freeradbiomed.2011.11.001.
39. Nelson MB, Swensen AC, Winden DR, Bodine JS, Bikman BT, Reynolds PR. Cardiomyocyte mitochondrial respiration is reduced by receptor for advanced glycation end-product signaling in a ceramide-dependent manner. Am J Physiol Heart Circ Physiol 309: H63–H69, 2015. doi:10.1152/ajpheart.00043.2015.
40. Nicholl ID, Bucala R. Advanced glycation endproducts and cigarette smoking. Cell Mol Biol (Noisy-le-grand) 44: 1025–1033, 1998.
41. Noakes PS, Holt PG, Prescott SL. Maternal smoking in pregnancy alters neonatal cytokine responses. Allergy 58: 1053–1058, 2003. doi:10.1034/j.1398-9995.2003.00290.x.
42. Noakes PS, Thomas R, Lane C, Mori TA, Barden AE, Devadason SG, Prescott SL. Association of maternal smoking with increased infant oxidative stress at 3 months of age. Thorax 62: 714–717, 2007. doi:10.1136/thx.2006.061630.
43. Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8: 49–62, 2007. doi:10.1038/nrm2083.
44. Prasad K, Dhar I, Caspar-Bell G. Role of advanced glycation end products and its receptors in the pathogenesis of cigarette smoke-induced cardiovascular disease. Int J Angiol 24: 75–80, 2015. doi:10.1055/s-0034-1396413.
45. Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 15: 16R– 28R, 2005. doi:10.1093/glycob/cwi053.
46. Reynolds PR, Kasteler SD, Cosio MG, Sturrock A, Huecksteadt T, Hoidal JR. RAGE: developmental expression and positive feedback regulation by Egr-1 during cigarette smoke exposure in pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 294: L1094–L1101, 2008. doi:10.1152/ajplung.00318.2007.
47. Reynolds PR, Kasteler SD, Schmitt RE, Hoidal JR. Receptor for advanced glycation end-products signals through Ras during tobacco smoke-induced pulmonary inflammation. Am J Respir Cell Mol Biol 45: 411–418, 2011. doi:10.1165/rcmb.2010-0231OC.
48. Robinson AB, Stogsdill JA, Lewis JB, Wood TT, Reynolds PR. RAGE and tobacco smoke: insights into modeling chronic obstructive pulmonary disease. Front Physiol 3: 301, 2012. doi:10.3389/fphys.2012.00301.
49. Rodriguez-Cuenca S, Cochemé HM, Logan A, Abakumova I, Prime TA, Rose C, Vidal-Puig A, Smith AC, Rubinsztein DC, Fearnley IM, Jones BA, Pope S, Heales SJ, Lam BY, Neogi SG, McFarlane I, James AM, Smith RA, Murphy MP. Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild- type mice. Free Radic Biol Med 48: 161–172, 2010. doi:10.1016/j.freeradbiomed.2009.10.039.
50. Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108: 949–955, 2001. doi:10.1172/JCI200114002.
51. Sekhon HS, Keller JA, Proskocil BJ, Martin EL, Spindel ER. Maternal nicotine exposure upregulates collagen gene expression in fetal monkey lung. Association with alpha7 nicotinic acetylcholine receptors. Am J Respir Cell Mol Biol 26: 31–41, 2002. doi:10.1165/ajrcmb.26.1.4170.
52. Semlali A, Witoled C, Alanazi M, Rouabhia M. Whole cigarette smoke increased the expression of TLRs, HBDs, and proinflammory cytokines by human gingival epithelial cells through different signaling pathways. PLoS One 7: e52614, 2012. doi:10.1371/journal.pone.0052614.
53. Smith RA, Hartley RC, Cochemé HM, Murphy MP. Mitochondrial pharmacology. Trends Pharmacol Sci 33: 341–352, 2012. doi:10.1016/j.tips.2012.03.010.
54. Snow BJ, Rolfe FL, Lockhart MM, Frampton CM, O’Sullivan JD, Fung V, Smith RA, Murphy MP, Taylor KM. A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson’s disease. Mov Disord 25: 1670–1674, 2010. doi:10.1002/mds.23148.
55. Sohet FM, Neyrinck AM, Pachikian BD, de Backer FC, Bindels LB, Niklowitz P, Menke T, Cani PD, Delzenne NM. Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice. Biochem Pharmacol 78: 1391–1400, 2009. doi:10.1016/j.bcp.2009.07.008.
56. Stangenberg S, Nguyen LT, Chen H, Al-Odat I, Killingsworth MC, Gosnell ME, Anwer AG, Goldys EM, Pollock CA, Saad S. Oxidative stress, mitochondrial perturbations and fetal programming of renal disease induced by maternal smoking. Int J Biochem Cell Biol 64: 81–90, 2015. doi:10.1016/j.biocel.2015.03.017.
57. Stogsdill MP, Stogsdill JA, Bodine BG, Fredrickson AC, Sefcik TL, Wood TT, Kasteler SD, Reynolds PR. Conditional overexpression of receptors for advanced glycation end-products in the adult murine lung causes airspace enlargement and induces inflammation. Am J Respir Cell Mol Biol 49: 128–134, 2013. doi:10.1165/rcmb.2013-0013OC.
58. Takuma K, Fang F, Zhang W, Yan S, Fukuzaki E, Du H, Sosunov A, McKhann G, Funatsu Y, Nakamichi N, Nagai T, Mizoguchi H, Ibi D, Hori O, Ogawa S, Stern DM, Yamada K, Yan SS. RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction. Proc Natl Acad Sci USA 106: 20021–20026, 2009. doi:10.1073/pnas.0905686106.
59. Tang D, Kang R, Zeh HJ III, Lotze MT. High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal 14: 1315–1335, 2011. doi:10.1089/ars.2010.3356.
60. Terán E, Racines-Orbe M, Toapanta J, Valdivieso L, Vega Z, Vivero S, Moya W, Chedraui P, Pérez-López FR. Maternal plasma and amni-otic fluid coenzyme Q10 levels in preterm and term gestations: a pilot study. Arch Gynecol Obstet 283, Suppl 1: 67–71, 2011. doi:10.1007/s00404-011-1894-x.
61. Vlahos R, Bozinovski S, Jones JE, Powell J, Gras J, Lilja A, Hansen MJ, Gualano RC, Irving L, Anderson GP. Differential protease, innate immunity, and NF-κB induction profiles during lung inflammation induced by subchronic cigarette smoke exposure in mice. Am J Physiol Lung Cell Mol Physiol 290: L931–L945, 2006. doi:10.1152/ajplung.00201.2005.
62. Wickström R. Effects of nicotine during pregnancy: human and experimental evidence. Curr Neuropharmacol 5: 213–222, 2007. doi:10.2174/157015907781695955.
63. Winden DR, Barton DB, Betteridge BC, Bodine JS, Jones CM, Rogers GD, Chavarria M, Wright AJ, Jergensen ZR, Jimenez FR, Reynolds PR. Antenatal exposure of maternal secondhand smoke (SHS) increases fetal lung expression of RAGE and induces RAGE-mediated pulmonary inflammation. Respir Res 15: 129, 2014. doi:10.1186/s12931-014-0129-7.
64. Zacharasiewicz A. Maternal smoking in pregnancy and its influence on childhood asthma. ERJ Open Res 2: pii: 00042-2016, 2016. doi:10.1183/23120541.00042-2016.
65. Zhang SP, Wu YW, Wu ZZ, Liu HY, Nie JH, Tong J. Up-regulation of RAGE and S100A6 in rats exposed to cigarette smoke. Environ Toxicol Pharmacol 28: 259–264, 2009. doi:10.1016/j.etap.2009.04.013.
66. Zhong CY, Zhou YM, Douglas GC, Witschi H, Pinkerton KE. MAPK/ AP-1 signal pathway in tobacco smoke-induced cell proliferation and squamous metaplasia in the lungs of rats. Carcinogenesis 26: 2187–2195, 2005. doi:10.1093/carcin/bgi189.